Clinical study of Dachaihu decoction in promoting gastrointestinal function recovery after gastrointestinal tumor surgery
- Conditions
- Gastrointestinal tumors
- Registration Number
- ITMCTR2200005722
- Lead Sponsor
- Shanxi Provincial Hospital of Traditional Chinese Medicine (Shanxi Provincial Institute of Traditional Chinese Medicine)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) Those who meet the diagnostic criteria for gastric cancer and colorectal cancer and require radical surgery;
(2) The age is between 18-80 years old, and the gender is not limited;
(3) No history of abdominal surgery;
(4) Informed consent, volunteer subjects.
(1) Pregnant and lactating women;
(2) Patients with severe primary cardiovascular and cerebrovascular disease, liver disease, kidney disease, hematological disease, lung disease, or serious diseases that affect their survival, such as tumors;
(3) History of severe gastrointestinal disease;
(4) Patients with mental disorders;
(5) Those who did not take the prescribed medication, or interrupted the treatment, had serious postoperative complications and could not determine the curative effect.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number of postoperative complications and the number of adverse reactions after taking the drug;Number and degree of abdominal pain and abdominal distension at 1, 3, and 7 days after operation;Gastrointestinal function recovery effect;Post-operative days of hospitalization and hospitalization expenses;Postoperative bowel sounds recovery and time to first exhaust and defecation;Changes in blood routine, C-reactive protein (CRP), vasoactive intestinal peptide (VIP), motilin (MOT), and somatostatin (SS) levels on the 1st, 3rd, and 7th days after operation;
- Secondary Outcome Measures
Name Time Method